Autism Biotech Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Autism Biotech General Information

Description

Developer of a biochemical test designed to offer early diagnosis of autism. The company's test develops therapies and detects autism from a drop of blood, enabling doctors to treat medical needs of patients with a Autism.

Contact Information

Website
www.autism-biotech.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • The Innovation Centre
  • Northern Ireland Science Park, Queen's Island
  • Belfast BT3 9DT
  • Northern Ireland, United Kingdom
+44 028
Primary Industry
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • The Innovation Centre
  • Northern Ireland Science Park, Queen's Island
  • Belfast BT3 9DT
  • Northern Ireland, United Kingdom
+44 028

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Autism Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 31-Mar-2020 Completed Out of Business
2. Early Stage VC 22-Dec-2014 Completed Startup
1. Grant Completed Startup
To view Autism Biotech’s complete valuation and funding history, request access »

Autism Biotech Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
To view Autism Biotech’s complete cap table history, request access »

Autism Biotech Patents

  • 11

    Total Documents Applications and Grants

  • Total Patents Families

  • 6

    Granted

  • Pending

  • Expiring in next 12 mo

Autism Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-9347956-B2 Biomarker and uses thereof in diagnosis, treatment of autism Inactive 16-Dec-2010
ES-2580136-T3 Novel biomarker and its uses in diagnosis, autism treatment Active 16-Dec-2010
AU-2011341776-A1 Novel biomarker and uses thereof in diagnosis, treatment of autism Active 16-Dec-2010
AU-2011341776-B2 Novel biomarker and uses thereof in diagnosis, treatment of autism Inactive 16-Dec-2010
CA-2821908-A1 Novel biomarker and uses thereof in diagnosis, treatment of autism Active 16-Dec-2010 G01N33/6896
To view Autism Biotech’s complete patent history, request access »

Ready to get started?

Request a free trial

Autism Biotech FAQs

  • When was Autism Biotech founded?

    Autism Biotech was founded in 2012.

  • Where is Autism Biotech headquartered?

    Autism Biotech is headquartered in Belfast, United Kingdom.

  • What industry is Autism Biotech in?

    Autism Biotech’s primary industry is Biotechnology.

  • Is Autism Biotech a private or public company?

    Autism Biotech is a Private company.

  • What is Autism Biotech’s current revenue?

    The current revenue for Autism Biotech is .

  • How much funding has Autism Biotech raised over time?

    Autism Biotech has raised $200K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process